Premium
Cripto‐1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF‐7 breast cancer cells
Author(s) -
Normanno Nicola,
Luca Antonella De,
Bianco Caterina,
Maiello Monica R.,
Carriero Maria V.,
Rehman Aasia,
Wechselberger Christian,
Arra Claudio,
Strizzi Luigi,
Sanicola Michele,
Salomon David S.
Publication year - 2004
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.10375
Subject(s) - mcf 7 , transfection , cancer research , cancer cell , biology , estrogen receptor , protein kinase b , cell culture , cell growth , medicine , breast cancer , cancer , signal transduction , microbiology and biotechnology , human breast , genetics
Cripto‐1 (CR‐1) is an epidermal growth factor (EGF)‐CFC protein that has been shown to signal through nodal/Alk‐4, PI3K/Akt, and/or ras/raf/MEK/MAPK pathways in mammalian cells, and that is frequently expressed in human primary breast carcinomas. In the present study, the human estrogen receptor positive, MCF‐7 breast cancer cell line, that expresses low levels of endogenous CR‐1, was transfected with a CR‐1 expression vector. MCF‐7 CR‐1 cells expressed high levels of a 25 kDa recombinant CR‐1 protein that was not detected in MCF‐7 cells transfected with a control vector (MCF‐7 neo). Overexpression of CR‐1 did not induce an estrogen independent phenotype in MCF‐7 cells. In fact, MCF‐7 CR‐1 cells showed a response to exogenous estrogens that was similar to MCF‐7 neo cells, and failed to grow in immunosuppressed mice in absence of estrogen stimulation. However, MCF‐7 CR‐1 cells showed a rate of proliferation in serum free conditions, and an ability to form colonies in soft‐agar that were higher as compared with MCF‐7 neo cells. More importantly, overexpression of CR‐1 enhanced the resistance to anoikis and the invasion ability of MCF‐7 cells. MCF‐7 CR‐1 cells showed levels of activation of both Akt and Smad‐2 that were significantly higher as compared with MCF‐7 neo. These findings suggest that CR‐1 overexpression might be associated with the progression towards a more aggressive phenotype in breast carcinoma, through the activation of both Akt and Smad‐2 signalling pathways. J. Cell. Physiol. 198: 31–39, 2004. © 2003 Wiley‐Liss, Inc.